Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists
- PMID: 11423097
- DOI: 10.1016/s0006-8993(01)02484-2
Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists
Abstract
Overproduction of the peptide amyloid beta (A beta) is a critical event in Alzheimer's disease (AD). Systemic administration of 3 M1-selective muscarinic agonists, AF102B, AF150S and AF267B, decreased cerebrospinal fluid (CSF) A beta concentrations; levels of CSF secreted beta-APP were not significantly altered. Rabbits treated for 5 days with s.c. injections of each drug (2 mg/kg/day) had levels of CSF A beta which were between 55 and 71% of control for A beta 1-40 and between 59 and 84% of control for A beta 1--42.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
